The alternative approach: genomic classifiers for prognostication in interstitial lung disease
- PMID: 37003611
- DOI: 10.1183/13993003.00033-2023
The alternative approach: genomic classifiers for prognostication in interstitial lung disease
Conflict of interest statement
Conflict of interest: S.A. Guler reports grants from Lindenhofstiftung Bern, Switzerland, CTU Grant Bern, Switzerland; lecture honoraria from Boehringer Ingelheim, Roche and Gebro, travel support from Boehringer Ingelheim, and advisory board participation with MSD, outside the submitted work. G.C. Goobie reports grants from Boehringer Ingelheim, Pulmonary Fibrosis Foundation, Canadian Lung Association and Michael Smith Health Research BC, and lecture honoraria from Boehringer Ingelheim, outside the submitted work.
Comment on
-
Interstitial lung disease progression after genomic usual interstitial pneumonia testing.Eur Respir J. 2023 Apr 1;61(4):2201245. doi: 10.1183/13993003.01245-2022. Print 2023 Apr. Eur Respir J. 2023. PMID: 36549706 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical